Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

60.39

-0.28 (0.46%)

as of Jul 23, 2026, 6:04:18 pm Market Open.

1632 watching

Investor Insights

Jul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.

Consensus

Cautious

Valuation

Fair Value

Similar

SLF

TOP PICK

With the closure of the John Hancock deal, should earn $4.50 next year. Good entry point.

BUY

Life-insurance companies will benefit from rising interest rates through their big bond portfolios.

HOLD

Has had a tremendous run-up in the last 3/4 weeks. Likes the management and feels the John Hancock acquisition will work out very well. Expects the uptrend will continue.

BUY

Very well-managed. Likes their diversification. Yield is low, but stock could continue going up.

BUY

Has a lot going for it. Likes their far Eastern operations.

BUY

Good management. Expect they will take a lot of costs out of the business with the acquisition of John Hancock. Expecting good Asian growth.

BUY ON WEAKNESS

Should be about to put up some good growth in earnings with their John Hancock acquisition. Expect some selling pressure when Hancock shareholders get their Manulife shares and start selling them. That will be an opportunity to buy.

BUY

Likes the life insurance business, this company in particular. Strong management. Expect they will be ruthless in cutting costs in John Hancock.

BUY

The merger with John Hancock was good and at a reasonable price. This should create cost synergies. Has a strong global presence.

BUY

Likes the insurance industry. Very solid company and well managed. A good hold.

BUY

The Hancock acquisition will add a lot over the next couple of years. Likes their position in Asia as well.

PAST TOP PICK

(A top pick December 16/03. Up 11.5%.) They consolidate very well. Good earnings.

DON'T BUY

Has done a very good job in its acquisition strategy. Will have some digesting problems with the John Hancock acquisition.

BUY

Can go a lot higher now that they John Hancock shareholders have agreed to the sale. Asian assets are now profitable. A good long-term hold.

BUY

Likes the insurance area.

Showing 2,026 to 2,040 of 2,283 entries

Most Recent Experts

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

John Stephenson

Stephenson & Company Capital Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Julien Nono-Womdim

Goodreid Investment Council

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)